This inventor holds 7 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Zürich, CH (2001 - 2002)
- Zurich, CH (2002)
Company Filing History:
Years Active: 2001-2002
Title: René Wyler: Innovator in Pharmaceutical Chemistry
Introduction
René Wyler is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate neuronal activity.
Latest Patents
René Wyler holds a total of 7 patents. His latest patents include innovations such as Quinolin-4-yl derivatives, which are phenyl substituted quinolin 4-yl derivatives and pharmaceutical compositions with activity as NMDA-receptor subtype selective blockers. These compounds are designed to modulate neuronal activity and plasticity, showcasing his expertise in creating impactful pharmaceutical solutions.
Career Highlights
Throughout his career, René has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has focused on developing novel therapeutic agents that address critical neurological conditions.
Collaborations
René has collaborated with notable colleagues, including Alexander Alanine and Marie-Paule Heitz Neidhart. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
René Wyler's innovative work in pharmaceutical chemistry continues to influence the field significantly. His contributions, particularly in the area of neuronal activity modulation, highlight the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile